Sorrento therapeutics

Beleggen in aandelen beurs New York, Dow Jones, Nasdaq-100 en S&P500

believer
Forum elite
Forum elite
Berichten: 5353
Lid geworden op: 14 jan 2015 17:30
waarderingen: 4573

Re: Sorrento therapeutics

Bericht door believer »

Even ter samenvatting

Abivertinib NSCLC - PHASE III
Abivertinib Lymphoma - Phase II
Abivertinib Prostate Cancer IND phase II
Abivertinib Lupus phase II IND
Abivertinib Covid 19 phase II
sepan liked last!



believer
Forum elite
Forum elite
Berichten: 5353
Lid geworden op: 14 jan 2015 17:30
waarderingen: 4573

Re: Sorrento therapeutics

Bericht door believer »


alwaysright
Forum veteraan
Forum veteraan
Berichten: 1001
Lid geworden op: 10 mei 2013 19:25
waarderingen: 436

Re: Sorrento therapeutics

Bericht door alwaysright »

Een beknopt overzicht van de aankoop van Sorrento

Vandana Singh , Benzinga Staff WriterSorrento Therapeutics To Buy ACEA Therapeutics For $38M In Stock

April 05, 2021 9:37am


Sorrento Therapeutics To Buy ACEA Therapeutics For $38M In Stock
Sorrento Therapeutics Inc (NASDAQ: SRNE) has agreed to acquire ACEA Therapeutics Inc in an all-stock deal of $38 million in shares of Sorrento common stock.
Sorrento will also pay the ACEA up to $450 million in additional milestone payments and 5-10% royalty of the annual net sales.
The acquisition will include late clinical-stage drug Abivertinib, AC0058, AC0939, and ACEA's extensive proprietary library of small molecules (over 1,000,000 compounds).
Lead candidate abivertinib is a small molecule tyrosine kinase inhibitor that selectively targets both a mutant form of the epidermal growth factor receptor and Bruton's tyrosine kinase. It is currently being studied as a Phase 2 treatment for COVID-19-induced respiratory compromise in the U.S. and Brazil.
AC0058 a BTK inhibitor, is currently in a Phase 1b trial for Lupus patients in the U.S.
The acquisition will also include ACEA's facility located in Quzhou, China, on a 23-acre campus with five buildings.
The facility currently can manufacture up to 5,000 kg/year of APIs and 50 million capsules of the final drug product.
The merger is expected to close in the second quarter of 2021.
Price Action: SRNE shares gained 1.5% at $8.13 in market trading on the last check Monday.

sepan
Forum veteraan
Forum veteraan
Berichten: 1647
Lid geworden op: 08 aug 2012 08:08
waarderingen: 770

Re: Sorrento therapeutics

Bericht door sepan »

Door de overname van ACEA geeft Sorrento aan hard te geloven in Abivertineb...en alzo de volledige omzet van dit product in de toekomst binnen te rijven (minus de royalties die ze doorstorten aan Acea)

Acea geeft dan weer aan hard te geloven in de pijplijn van Sorrento door de overnameprijs te ontvangen in "aandelen van Sorrento". Dat doe je enkel als je gelooft in het bedrijf Sorrento dat de koers flink omhoog kan gaan... :up:
believer liked last!

_Jack_
Forum gebruiker
Forum gebruiker
Berichten: 236
Lid geworden op: 29 jan 2018 20:28
waarderingen: 105

Re: Sorrento therapeutics

Bericht door _Jack_ »

Hoe meer ze hier pumpen hoe meer het aandeel stagneert of zelfs wegzakt. :D
Mag stilaan wel eens terug richting de 15 gaan me dunkt.

ancaoli
Forum elite
Forum elite
Berichten: 2095
Lid geworden op: 28 jan 2018 18:54
waarderingen: 1127

Re: Sorrento therapeutics

Bericht door ancaoli »

In afwachting van meer opbeurende beurskoersen laat ik de wetenschap aan het woord (of ben ik nu aan het pumpen 😉?)

https://www.sciencedirect.com/science/a ... 9921002351

Methodology from the study:
"This paper focuses on identifying inhibitors that target SARS-CoV-2 proteases, PLPRO and 3CLPRO, which control the duplication and manages the life cycle of SARS-CoV-2. We have carried out detailed in silico Virtual high-throughput screening using Food and Drug Administration (FDA) approved drugs from the Zinc database, COVID-19 clinical trial compounds from Pubchem database, Natural compounds from Natural Product Activity and Species Source (NPASS) database and Maybridge database against PLPRO and 3CLPRO proteases."

The authors concluded abivertinib to be a potential top contender to tackle Covid19 based on the screening criteria of the study. Abivertinib was also recommended by the study's authors in their conclusion as a starting point to in the attempt develop Covid19 drug/treatment from existing pharma compounds.
Vaste Portefeuille:Recticel, WRN, Accentis, Global G, Roularta, Agfa, Ontex, OCI, Sorrento, Inventiva

believer
Forum elite
Forum elite
Berichten: 5353
Lid geworden op: 14 jan 2015 17:30
waarderingen: 4573

Re: Sorrento therapeutics

Bericht door believer »


Stefkamielkafkajr
Forum actieveling
Forum actieveling
Berichten: 929
Lid geworden op: 25 dec 2013 21:48
waarderingen: 353

Re: Sorrento therapeutics

Bericht door Stefkamielkafkajr »

amc entertainment holdings,aegon,, euronav, acacia pharma,fagron,,, greenyard ,pharming, , econocom.Xfab.oxurion.sorrento therapeutics.luckin coffe adr , recticel, foresight autonomous

ancaoli
Forum elite
Forum elite
Berichten: 2095
Lid geworden op: 28 jan 2018 18:54
waarderingen: 1127

Re: Sorrento therapeutics

Bericht door ancaoli »

Heel vreemd artikel met vooral complete voorbijgestreefde info: covitrack test results en CFO weg :lol:
Vaste Portefeuille:Recticel, WRN, Accentis, Global G, Roularta, Agfa, Ontex, OCI, Sorrento, Inventiva

believer
Forum elite
Forum elite
Berichten: 5353
Lid geworden op: 14 jan 2015 17:30
waarderingen: 4573

Re: Sorrento therapeutics

Bericht door believer »








Plaats reactie